Prognostic value of (18)F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer

This study evaluated the prognostic value of positron emission tomography/computed tomography (PET/CT) using (18)F‐fluoroazomycin arabinoside (FAZA) in patients with advanced non‐small‐cell lung cancer (NSCLC) compared with (18)F‐fluorodeoxyglucose (FDG). Thirty‐eight patients with advanced NSCLC (s...

Descripción completa

Detalles Bibliográficos
Autores principales: Saga, Tsuneo, Inubushi, Masayuki, Koizumi, Mitsuru, Yoshikawa, Kyosan, Zhang, Ming‐Rong, Tanimoto, Katsuyuki, Horiike, Atsushi, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714693/
https://www.ncbi.nlm.nih.gov/pubmed/26292100
http://dx.doi.org/10.1111/cas.12771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714693/
https://www.ncbi.nlm.nih.gov/pubmed/26292100
http://dx.doi.org/10.1111/cas.12771

Ejemplares similares